{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:55:53Z","timestamp":1792580153794,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cgh.2024.06.047","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:19:07Z","timestamp":1723313947000},"page":"914-926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Perianal Fistulizing Crohn\u2019s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8424-202X","authenticated-orcid":false,"given":"Luke N.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulak","family":"Anandabaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Geldof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Dige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilli","family":"Lundby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"D\u2019Hoore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bislenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"De Looze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triana","family":"Lobaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Van de Putte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carvello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Gecse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Hompes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"van der Bilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Lightner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serre-Yu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Holubar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik S.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Behrenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Sahnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Tozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.06.047_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.dld.2007.07.154","article-title":"The natural history of perianal Crohn's disease","volume":"39","author":"Ingle","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12955-020-01622-7","article-title":"Burden of disease and adaptation to life in patients with Crohn\u2019s perianal fistula: a qualitative exploration","volume":"18","author":"Adegbola","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cgh.2024.06.047_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.crohns.2007.08.004","article-title":"Effect of phenotype on health care costs in Crohn\u2019s disease: a European study using the Montreal classification","volume":"1","author":"Odes","year":"2007","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.06.047_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S2468-1253(22)00007-3","article-title":"Classifying perianal fistulising Crohn\u2019s disease: an expert consensus to guide decision-making in daily practice and clinical trials","volume":"7","author":"Geldof","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.06.047_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijsu.2019.08.003","article-title":"Risk factors for recurrence after anal fistula surgery: a meta-analysis","volume":"69","author":"Zubing","year":"2019","journal-title":"Int J Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11605-006-0029-3","article-title":"Risk of fecal diversion in complicated perianal Crohn\u2019s disease","volume":"11","author":"Mueller","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apt.13356","article-title":"Systematic review with meta-analysis: faecal diversion for management of perianal Crohn\u2019s disease","volume":"42","author":"Singh","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.06.047_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-0038-1677004","article-title":"Diverting ostomy: for whom, when, what, where, and why","volume":"32","author":"Plasencia","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ibd\/izab086","article-title":"Fecal diversion for perianal Crohn disease in the era of biologic therapies: a multicenter study","volume":"28","author":"McCurdy","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-2007-991032","article-title":"Management of nonhealing perineal wounds","volume":"20","author":"Genua","year":"2007","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib11","first-page":"466","article-title":"Cutaneous Crohn\u2019s disease after proctocolectomy for medically refractory colonic Crohn\u2019s disease: a case series and review of the literature","volume":"36","author":"Naffouj","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib12","first-page":"1067","article-title":"Symptom amelioration in Crohn\u2019s perianal fistulas using video-assisted anal fistula treatment (VAAFT)","volume":"12","author":"Adegbola","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.06.047_bib13","first-page":"655","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"McMillan","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.cgh.2024.06.047_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/apt.14814","article-title":"Review article: pathogenesis of Crohn\u2019s perianal fistula-understanding factors impacting on success and failure of treatment strategies","volume":"48","author":"Tozer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.06.047_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.sla.0000161030.25860.c1","article-title":"Perianal Crohn disease: predictors of need for permanent diversion","volume":"241","author":"Galandiuk","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib16","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2024.06.047_bib17","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.06.047_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","article-title":"Treatment of perianal fistulizing Crohn\u2019s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement","volume":"9","author":"Regueiro","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1463-1318.2004.00749.x","article-title":"Infliximab in the surgical management of complex fistulating anal Crohn\u2019s disease","volume":"7","author":"Talbot","year":"2005","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.806497","article-title":"Impact on quality of life of seton placing in perianal Crohn\u2019s disease","volume":"8","author":"Angriman","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.cgh.2024.06.047_bib21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/2050640620934915","article-title":"Wound healing of metastatic perineal Crohn\u2019s disease using hyperbaric oxygen therapy: a case series","volume":"8","author":"Lansdorp","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2024.06.047_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/codi.12500","article-title":"Healing under pressure: hyperbaric oxygen and myocutaneous flap repair for extreme persistent perineal sinus after proctectomy for inflammatory bowel disease","volume":"16","author":"Chan","year":"2014","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.06.047_bib24","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA Clinical Practice Guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.06.047_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ibd\/izac103","article-title":"Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn\u2019s disease: systematic review and network meta-analysis of randomized controlled trials","volume":"29","author":"Shehab","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MEG.0000000000002552","article-title":"Network meta-analysis: efficacy and safety of treatments for fistulising Crohn\u2019s disease","volume":"35","author":"Chahal","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.06.047_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.06.047_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12876-021-02078-9","article-title":"Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn\u2019s disease: a retrospective cohort study","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib29","first-page":"1813","article-title":"Therapeutic drug monitoring in perianal fistulizing Crohn\u2019s disease","volume":"11","author":"Zulqarnain","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cgh.2024.06.047_bib30","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3748\/wjg.v28.i23.2597","article-title":"Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn\u2019s disease","volume":"28","author":"Gu","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.14309\/ajg.0000000000001111","article-title":"Higher postinduction infliximab concentrations are associated with improved clinical outcomes in fistulizing Crohn\u2019s disease: an ACCENT-II post hoc analysis","volume":"116","author":"Papamichael","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3748\/wjg.v28.i9.961","article-title":"Relationship between clinical remission of perianal fistulas in Crohn\u2019s disease and serum adalimumab concentrations: a multi-center cross-sectional study","volume":"28","author":"Sirmai","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043921","article-title":"Prospective randomised controlled trial of adults with perianal fistulising Crohn\u2019s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol","volume":"11","author":"Gu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.cgh.2024.06.047_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.06.047_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221148254","article-title":"Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn\u2019s disease","volume":"16","author":"Newman","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2024.06.047_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ibd.20073","article-title":"Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial","volume":"13","author":"Hart","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1463-1318.2011.02613.x","article-title":"Self-reported depressive symptoms and suicidal feelings in perianal Crohn\u2019s disease","volume":"14","author":"Mahadev","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/codi.15375","article-title":"GREP members (Groupe de Recherche en Proctologie). Assessment of sexual dysfunction in patients with perianal Crohn\u2019s disease","volume":"23","author":"Boudiaf","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.06.047_bib40","first-page":"A17","article-title":"O30: Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials","volume":"71","author":"Laurent","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.06.047_bib41","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/MIB.0000000000000842","article-title":"Ustekinumab for the treatment of refractory Crohn\u2019s disease: the Spanish experience in a large multicentre open-label cohort","volume":"22","author":"Khorrami","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.06.047_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jgh.16358","article-title":"Efficacy and safety of risankizumab for Crohn\u2019s disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies","volume":"39","author":"Gao","year":"2024","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.06.047_bib43","first-page":"A62","article-title":"P48 Filgotinib for perianal fistulizing Crohn\u2019s disease: the phase 2 DIVERGENCE 2 study","volume":"71","author":"Morison","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.06.047_bib44","doi-asserted-by":"crossref","first-page":"i620","DOI":"10.1093\/ecco-jcc\/jjac190.0621","article-title":"P491 Efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn\u2019s disease","volume":"17","author":"Colombel","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.06.047_bib45","first-page":"406","article-title":"Efficacy and safety of dual biologic therapy in patients with inflammatory bowel disease: a review of the literature","volume":"17","author":"Gold","year":"2021","journal-title":"Gastroenterol Hepatol (N Y)"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652400692X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652400692X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:55Z","timestamp":1762549975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652400692X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S154235652400692X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.06.047","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perianal Fistulizing Crohn\u2019s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}